Histamine is not only a crucial cytokine in the periphery but also an important neurotransmitter and neuromodulator in the brain. It is known to act on metabotropic H1-H4 receptors, but the existence of directly histamine-gated chloride channels in mammals has been suspected for many years. However, the molecular basis of such mammalian channels remained elusive whereas in invertebrates, genes for histamine-gated channels have been already identified.
In this report we demonstrate that histamine can directly open vertebrate ion channels and identified β β β β subunits of GABA(A) receptors as potential candidates for histamine-gated channels. In Xenopus oocytes expressing homomultimeric β β β β channels, histamine evoked currents with an EC 50 of 212 µM (β β β β 2 2 2
2 ) and 174 µM (β β β β 3 3 3
3 ), whereas GABA is only a very weak partial agonist. We tested several known agonists and antagonists for the histamine binding site of H1-H4 receptors and described for β β β β channels a unique pharmacological profile distinct from either of these receptors. In heteromultimeric channels composed of α α α α 1 β β β β 2 or α α α α 1 β β β β 2 γ γ γ γ 2 subunits, we found that histamine is a modulator of the GABA response rather than an agonist, as it potentiates GABA-evoked currents in a γ γ γ γ 2 subunit controlled manner. Despite the vast number of synthetic modulators of GABA(A) receptors widely used in medicine, which act on several distinct sites, only few endogenous modulators have yet been identified. We show here for the first time that histamine modulates heteromultimeric GABA(A) receptors and may thus represent an endogenous ligand for an allosteric site.
Ligand-gated ion channels (LGIC) mediate the fast responses of cells to neurotransmitters (1) . A universal feature of LGIC subunits is a common topology, comprising four membrane-spanning segments (M1-M4) and a huge N-terminal extracellular domain with a hyperconserved cysteine-loop motif. In vertebrates, this 'cys-loop' family of phylogenetically related genes codes for anion and cation channels activated by acetylcholine and serotonin (cation channels) or GABA and glycine (anion channels) (1;2). Despite the many years of intensive research on such ion channels, recent reports revealed unexpected new findings about this channel family. In vertebrates, a gene for zinc-gated ion channels was recently discovered (3). In insects, new classes of ligand-gated chloride channels gated by histamine or pH, and cation channels gated by GABA were reported (4) (5) (6) (7) .
Histamine is a neurotransmitter and neuromodulator acting on the metabotropic H1-H4 receptors (8) . In addition, a direct activation of mammalian anion channels has been postulated (9) . Histamine-containing neurons are found exclusively in the tuberomamillary nucleus (TM nucleus) of the hypothalamus (10) . The GABA-synthesizing enzyme, glutamate acid decarboxylase, and GABA are also seen in most TM neurons and many neurons in the TM nucleus contain both GABA and histamine (10) . The molecular structure of a potential mammalian histaminegated channel is still elusive but in invertebrates, two genes for histamine-gated channels have been identified (4;5;11;12) . In addition, GABA and histamine can activate the same ion channel (13) . Therefore we hypothesized that a subtype of mammalian GABA receptors may be a good candidate mediating the effect of histamine in vertebrates. GABA is the major inhibitory neurotransmitter in the CNS. Most of the rapid inhibitory neurotransmission in the CNS is mediated by the GABA type A receptors (14) . GABA(A) receptors are heteropentameric proteins constructed of various subunits (α, β, γ, δ, θ, ε and π). The most prominent native receptors are heteromultimers of α, β and γ subunits (14) but at least in recombinant systems, functional homomultimeric receptors composed of β or γ subunits alone exist (15) (16) (17) (18) (19) . Such homomultimeric ion channels differ in many aspects from the conventional, heteromultimeric GABA(A) receptors and were therefore candidates for receptors with unexpected new properties. (20) . To exclude that the observed histamine effects depend on the complexation of such divalent cation contaminations, potentiation and doseresponse curves experiments were performed in Ringer's solution prepared with ultra-pure water ("AMPUWA" water, Fresenius, Bad Homburg, Germany) as suggested (20) . In experiment targeting the effect of histamine on heteromultimeric receptors, it was vital to ensure the absence of any contaminating population of homomultimeric channels composed of ß subunits when expressing α 1 β 2 γ 2 receptors as such could mimic a histamine effect. In preliminary studies with oocytes injected with a 1:1:1 ratio of α 1 β 2 γ 2 subunits, in some experiments small currents were directly evocable by 1 mM histamine, obviously caused by a small, contaminating population of homomultimeric β 2 channels. Therefore, we injected an excess of α 1 and γ 2 over β 2 subunit RNA (ratio α 1 :10, β 2 : 1, γ 2 :2). In these oocytes, 1 mM histamine itself evoked no detectable currents, (<< 1% of the maximum GABA evoked current) proving the absence of a contaminating population of homomultimeric β 2 -subunits. Same is valid for receptors composed of α 1 β 2 subunits, where the α subunit was also injected in a tenfold excess over ß. To ensure the incorporation of the γ 2L subunit, oocytes were screened with 10 µM Zn 2+ in the presence of GABA. While αβ subunit combinations are highly sensitive for an inhibition by Zn 2+ , the αβγ isoforms are insensitive.
Experimental Procedures

GABA(A) cDNAs and RNAs-
Statistics-
For electrophysiological measurements, statistical analysis and curve fitting was done by Hill equation using SigmaPlot V8.0 (Systat Software, San Jose, CA). All mean values are ± SEM.
Patch-clamp experiments-HEK293 cells were maintained under standard conditions in a minimum essential medium supplemented with 10% foetal bovine serum, 100 units/ml penicillin and streptomycin, and 2 mM Lglutamine. Semiconfluent cells were transfected in 35-mm dishes (Becton Dickinson, Heidelberg, Germany) by using standard CaP-precipitation, 48-72 hr after transfection. Recordings were performed using the whole-cell mode of the patch-clamp technique. Cells were maintained in an extracellular recording solution containing 140 mM NaCl, 5 mM KCl, 2 mM MgCl 2 , 2 mM CaCl 2 , 10 mM HEPES, 10 mM glucose, pH 7.4. Patch electrodes were pulled from borosilicate glass and fire-polished to 4-6 MOhm tip resistance using a horizontal pipette puller (Zeitz Instr., Munich, Germany). The pipette solution contained 140 mM KCl, 1 mM MgCl 2 , 0.1 mM CaCl 2 , 5 mM EGTA, 10 mM HEPES, pH 7.4 for recordings. Recordings were carried out using a HEKA EPC7 amplifier. Membrane potential was held at -40 mV.
RESULTS
Homomultimeric ß channels -We investigated the action of histamine on homomultimeric GABA(A) receptors. Complementary RNAs (cRNA) from ß 2-3 subunits were expressed in Xenopus laevis oocytes. 2-6 days after injection, histamineand GABA-elicited currents were recorded in the voltage clamp configuration. We used the known ß channel agonist pentobarbital (Pb) (15;16;18) as a positive control and found that 3 mM histamine could also directly open homomultimeric ß 3 channels with an average current amplitude of 536 nA (±95, n=15). Compared to saturating concentrations of Pb, histamine evoked currents were smaller, reaching 67 % (±6%, n=8, p=0.008) of the Pb response (Fig. 1A) . 3 mM histamine also opened homomultimeric ß 2 channels, although with lower average amplitudes (132 nA (±21, n=7), data not shown). Dose-response curves show that homomultimeric receptors composed of ß 2 or ß 3 were similarly sensitive to histamine, with an EC 50 of 212 µM ± 29 µM (n = 4) and an EC 50 of 174 µM ± 14 µM (n = 11), respectively (Fig. 1B,C) . It has been reported that homomultimeric β channels are activated by GABA (15) (16) (17) (18) . Our experiments expressing ß 2 or ß 3 confirmed the effect of GABA but even at high, saturating GABA concentrations (3 mM) the amplitudes were only 10 % of the histamine-activated currents (ß 3 : I GABA (3 mM) / I Histamine (10 mM) = 0.11 ± 0.012 (n = 10)). GABA is a weak partial agonist compared to histamine (Fig.  1A) . Homomultimeric channels composed of GABA(A) ß subunits are rather histaminegated than GABA-gated channels. Histamine evoked a current reversing typically at -23 mV under standard ion conditions in oocytes expressing ß 3 (Fig. 1D) , which is consistent with the previously reported chloride selectivity of β channels (15) .
The histamine effect is independent on the oocyte expression system. In whole cell-patch clamp experiments on Human Embryonic Kidney 293 (HEK293) cells expressing ß 3 channels (Fig. 1E ), 1 mM histamine evoked currents with an average amplitude of 203 pA (±31, n=8) which was typically 60% of the pentobarbital response (21) . The EC 50 of histamine with 386 µM (±24, n=6) was in the same range as in Xenopus oocytes (Fig. 1F) .
Pharmacology of the histamine responseThe currents evoked by 1 mM histamine expressed in Xenopus laevis oocytes expressing ß 3 were completely blocked by 10 µM PTX but 100 µM of the GABAantagonists bicuculline or gabazine were ineffective (data not shown). Histamine analogs like histidine and tele-methylhistamine were also found to be agonists for β 3 channels ( Fig. 2A, supplementary Fig. 1,2) , although with lower potencies (EC 50 1.14 mM ± 0.15 µM (n = 5) and (EC 50 1.1 mM ± 0.13 µM (n = 3), respectively) demonstrating that metabolic precursors and metabolites could also be active agonists. For the histamine-binding sites of metabotropic H1-H4 receptors specific agonists and antagonists are known (22). We investigated whether the histamine binding site of GABA(A) β subunits match one of those pharmacological profiles. In oocytes expressing β 3 channels, current evoked by 300 µM histamine was effectively blocked by the H3/4 antagonist thioperamide. Higher concentrations of thioperamide additionally blocked a fraction of spontaneously open channels as indicated by the apparent 'outward' current; it thus behaves like an 'inverse agonist' (Fig. 2B) . The IC 50 was 7.2±0.7 µM (n=5) in the absence of histamine (Fig. 2D) . In the presence of 300 µM histamine, the IC 50 for thioperamide was 32±3.8 µM (n=5) determined by a 4 parameter Hill fit of the complete blocking curve, but it would be in the range of 10 µM, if one would relate it only to the histamine evoked current. Therefore, the found value is only a rough estimate, as the population of open channels interferes with the analysis. Next, we tested if thioperamide and histamine might compete for the same binding site and found that at 10 mM histamine, thioperamide was a far less effective blocker; a clear indication for a competitive mechanism (Fig. 2C) . The H2 antagonist famotidine (IC 50 = 154±21 µM (n = 5)) and the H1/2 agonist HTMT (IC 50 = 162±19 µM (n = 5)) were also found to be blockers of the histamine-evoked current as well as the population of open channels (supplementary Fig. 3) .
Other ligands for metabotropic histamine receptors, such as cimetidine (H2 antagonist), pyrilamine (H1 antagonist) and dimaprit (H2 agonist), were ineffective in concentrations up to 500 µM (data not shown). Our data reveal that the histamine-binding site of GABA(A) β subunits has a unique pharmacology not matching any of the metabotropic receptors.
Histamine analog H2 blockers act on heteromultimeric GABA(A) receptors as reported previously (23;24) . Our findings may explain the molecular basis of this observed action as we found that such molecules directly act on ß subunits. But our findings imply that GABA(A) receptors are not specifically blocked by H2 antagonists alone but agonists or antagonists of other metabotropic histamine receptors act also.
Histamine's action on α 1 β 2 γ 2 receptors -
The action of histamine on the β subunits resembles that of allosteric GABA(A) modulators like propofol and barbiturates which also activate currents at homomultimeric β receptors directly (15;16;18) . At heteromultimeric GABA(A) receptors, such modulators potentiate the action of GABA (25) . To investigate the action of histamine on heteromultimeric receptors, we investigated recombinant α 1 β 2 γ 2 receptors, which are the most abundant GABA(A) synaptic receptor type in the CNS (14) . In oocytes expressing α 1 β 2 γ 2 receptors, 1 mM histamine potentiated the current evoked by 10 µM GABA (about EC 30 ) (Fig. 3A) . The potentiation at 10 µM GABA was 1.5 fold on average (I(GABA + histamine)/I(GABA) = 1.52±0.43, n=12) but had a considerable variability, reaching from zero in few oocytes up to 2.4 fold. In the same set of oocytes, 1 mM histamine was virtually ineffective on the current evoked by saturating concentations (300 µM) of GABA (1.01±0.06) pointing out that potentiation by histamine was significantly much more effective at submaximal GABA concentrations (p=0.0012, n=12). This fit to the observation that 1 mM histamine significantly lowered the EC 50 for GABA from 15.8 ± 2.1 µM to 11.1 ± 1.7 µM (p=0.0044, n = 5) (Fig. 3A, B) . 1 mM histamine itself didn't evoke detectable currents, (<< 1% of the maximum GABA evoked current, Fig. 3A) .
The histamine potentiation of recombinant GABA(A) receptors was independent of the expression system and could also be observed at α 1 β 2 γ 2 receptors expressed in HEK293 cells. Histamine showed potentiating effects similar to those in oocytes, demonstrating that the effect was not restricted to the oocyte expression system. At cells stimulated with 3 µM GABA, 1 mM histamine evoked an up to 2.0-fold potentiation of the GABA current (1.4-fold potentiation on average; n = 12) (Fig.  3C ), but 1 mM histamine alone never evoked any detectable currents.
Histamine's action on α 1 β 2 receptors -It is known that the presence of a γ 2 subunit modulates the potentiation by allosteric modulators like benzodiazepines, that are only effective in γ subunit containing receptors (26) . In the case of potentiators acting on ß subunits like propofol, it was reported that the γ 2 subunit alters the mode of potentiation (27) . To address the question if the presence of a γ 2 subunit alters histamine's potentiation, we compared the effect of histamine on heteromultimeric α 1 β 2 and α 1 β 2 γ 2 receptors. In oocytes expressing α 1 β 2 , receptors, 1 mM histamine potentiated currents evoked by GABA. Histamine potentiation was strongly dependent on the GABA concentration but in a different manner as for α 1 β 2 γ 2 receptors. At α 1 β 2 GABA receptors, 1 mM histamine potentiated best at saturating GABA concentrations (300 µM) but in the average not at submaximal concentrations of 3 µM GABA (Fig. 3D,E) . At 300 µM GABA, average potentiation was 1.26 fold (±0.24, n = 14) and significantly greater (p=0.013, n=14) than at 3 µM GABA in the same set of oocytes (1.04±0.07, n = 14). Also in these experiments, some oocytes had GABA currents not potentiated by histamine at all. 1 mM histamine itself didn't evoke detectable currents (<< 1% of the maximum GABA evoked current). The average EC 50 for GABA was not significantly affected by 1 mM histamine (p=0.22, n=4). These experiments demonstrate that the γ 2 subunit has a vital, modulatory role in histamine potentiation of GABA(A) receptors.
Histamine potentiates GABA receptors in a dose-dependent manner. At α 1 β 2 receptors, the EC 50 of potentiation is 965 µM (± 306, n = 4) (Fig. 3 F) . The potentiation effect requires higher histamine concentrations as the direct action on homomultimeric β 2 channels.
DISCUSSION
Our study shows that histamine directly opens homomultimeric GABA(A) receptors that thus can function as histamine-gated channels. The existence of such histaminegated chloride channels in mammals has been suggested for a long time (4;9). The putative histamine receptor described by Hatton and Yang (9) in the SON nucleus shares some pharmacological similarities with homomultimeric ß channels (e.g. the PTXsensitivity). However, there are also some pronounced differences (e.g. the affinity for histamine and the sensitivity to cimetidine), suggesting that the native receptor may need additional components. Compared to the high affinity of metabotropic histamine receptors, the EC 50 of ß-channels with app. 200-400 µM is quite low and they are not expected to be activated by typical extracellular histamine concentrations in the brain. However, at synaptic transmission, high enough concentrations could be reached in the synaptic cleft as histamine concentration in synaptic vesicles be as high as 670 mM (28) . Nevertheless, our findings support the idea that GABA(A) subunits may be vital parts of potential native mammalian histamine-gated channels and could provide the histamine binding site.
Further, we demonstrate that histamine potentiates GABA responses in heteromultimeric receptors and thereby identified a new type of allosteric potentiator for GABA(A) receptors. The mode of potentiation resembles anaesthetics such as propofol: like propofol it targets ß subunits, opens homomultimeric ß channels directly but modulates the GABA response at heteromultimeric channels (15;16;18;27;29;30) . Also the influence of the γ 2 subunit is the similar. In receptors composed of α 1 β 2 subunits, both histamine and propofol potentiate effectively at saturating GABA concentrations increasing the maximally evoked currents. In contrast, at α 1 β 2 γ 2 receptors, histamine and propofol were non effective at high concentrations but are shifting the GABA dose-response curve leftwards (30) . In our oocyte expression system, we found that at recombinant heteromultimeric receptors the strength of histamine potentiation was quite variable, an indication that potentiation might be regulated for example posttranscriptionally by a yet unknown mechanism. Such variability of receptor properties in recombinant expression systems is often observed and can have several reasons: for example, differences in expression level (31) , receptor clustering (32) , different amounts of γ subunits relative to α or β in αβγ GABA(A) receptors (33) as well as different receptor phosphorylation, just to mention a few. Interestingly, phosphorylation regulates GABA(A) receptor potentiation by neurosteroids (34) .
In contrast to the variability of the histamine effect on heteromultimeric channels, exclusively all measured homomultimeric ß channels responded to histamine and none were found that only responding to GABA or pentobarbital.
For GABA(A) receptors, about 10 different sites for allosteric modulators are known including neurosteroides, benzodiazepines, general anaesthetics and ethanol (25;35) . With the exception of neurosteroides, no endogenous modulators have been identified so far. Our findings that histamine potentiates GABA action on GABA(A) receptors suggests that it is an endogenous ligand for an allosteric site located on the β subunits. Therefore, our results suggest an additional function for histamine in vivo, apart from the action on metabotropic histamine and NMDA receptors (36) . All histaminergic neurons in the mammalian brain are found in the TM nucleus, and send axons to almost all parts of the CNS (10) . Some of these neurons contain both GABA and histamine. In addition, histamine could diffuse out of a histaminergic synapse by a 'spillout' effect as described for GABA-ergic synapses (37) and thus may act on neighbouring synaptic or extrasynaptic GABA(A) receptors. Further, mast cells in the brain are a source for histamine. Mast cells occur in the CNS of many species and up to 50% of the brain histamine is attributable to the presence of these cells. By direct gating of channels or by affecting GABA(A) receptor currents, histamine should modulate processes in which rapid GABA-evoked currents participate (8) .
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